BRPI0612396A2 - composto ou um sal do mesmo, e, ativador para receptor ativado por proliferador de peroxissoma delta - Google Patents
composto ou um sal do mesmo, e, ativador para receptor ativado por proliferador de peroxissoma deltaInfo
- Publication number
- BRPI0612396A2 BRPI0612396A2 BRPI0612396A BRPI0612396A BRPI0612396A2 BR PI0612396 A2 BRPI0612396 A2 BR PI0612396A2 BR PI0612396 A BRPI0612396 A BR PI0612396A BR PI0612396 A BRPI0612396 A BR PI0612396A BR PI0612396 A2 BRPI0612396 A2 BR PI0612396A2
- Authority
- BR
- Brazil
- Prior art keywords
- delta
- salt
- compound
- activated receptor
- peroxisome proliferator
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005197484 | 2005-07-06 | ||
| PCT/JP2006/313636 WO2007004733A1 (ja) | 2005-07-06 | 2006-07-04 | ペルオキシソーム増殖剤活性化受容体δの活性化剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0612396A2 true BRPI0612396A2 (pt) | 2016-09-06 |
Family
ID=37604587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0612396A BRPI0612396A2 (pt) | 2005-07-06 | 2006-07-04 | composto ou um sal do mesmo, e, ativador para receptor ativado por proliferador de peroxissoma delta |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20100029949A1 (pt) |
| EP (1) | EP1916247A4 (pt) |
| JP (1) | JPWO2007004733A1 (pt) |
| KR (1) | KR20080032155A (pt) |
| CN (1) | CN101248065A (pt) |
| AU (1) | AU2006266711A1 (pt) |
| BR (1) | BRPI0612396A2 (pt) |
| CA (1) | CA2614315A1 (pt) |
| IL (1) | IL188616A0 (pt) |
| NO (1) | NO20080628L (pt) |
| RU (1) | RU2008104422A (pt) |
| WO (1) | WO2007004733A1 (pt) |
| ZA (1) | ZA200800892B (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102643248A (zh) | 2006-04-18 | 2012-08-22 | 日本化学医药株式会社 | 过氧化物酶体增殖剂激活受体δ的激活剂 |
| JPWO2008016175A1 (ja) * | 2006-08-03 | 2009-12-24 | 日本ケミファ株式会社 | ペルオキシソーム増殖剤活性化受容体の活性化剤 |
| TWI440633B (zh) | 2008-04-15 | 2014-06-11 | Nippon Chemiphar Co | Activator of Activated Receptors for Peroxisome Producers |
| JP2013006769A (ja) * | 2009-10-08 | 2013-01-10 | Nippon Chemiphar Co Ltd | ペルオキシソーム増殖剤活性化受容体の活性化剤 |
| CN113912547B (zh) | 2020-07-10 | 2024-04-30 | 成都凡诺西生物医药科技有限公司 | 取代苯丙咪唑类衍生物及其应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5089514A (en) * | 1990-06-14 | 1992-02-18 | Pfizer Inc. | 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
| KR100436812B1 (ko) * | 1995-01-06 | 2004-08-31 | 도레이 가부시끼가이샤 | 벤젠축합헤테로환유도체및그유도체를유효성분으로함유하는의약조성물 |
| EP0994095A1 (en) * | 1996-12-24 | 2000-04-19 | Nippon Chemiphar Co., Ltd. | Propionic acid derivatives |
| US20020032330A1 (en) * | 1996-12-24 | 2002-03-14 | Yutaka Nomura | Propionic acid derivatives |
| JP2001354671A (ja) * | 2000-04-14 | 2001-12-25 | Nippon Chemiphar Co Ltd | ペルオキシソーム増殖剤応答性受容体δの活性化剤 |
| WO2003033493A1 (fr) * | 2001-10-12 | 2003-04-24 | Nippon Chemiphar Co.,Ltd. | Activateur du recepteur $g(d) active par le proliferateur de peroxisome |
| WO2004022551A1 (ja) * | 2002-09-06 | 2004-03-18 | Takeda Pharmaceutical Company Limited | フランまたはチオフェン誘導体およびその医薬用途 |
| US7528160B2 (en) * | 2003-01-06 | 2009-05-05 | Eli Lilly And Company | Fused heterocyclic derivatives as PPAR modulators |
| WO2004071509A1 (ja) * | 2003-02-12 | 2004-08-26 | Nippon Chemiphar Co., Ltd. | オリゴデンドロサイト分化促進剤 |
| US7244763B2 (en) * | 2003-04-17 | 2007-07-17 | Warner Lambert Company Llc | Compounds that modulate PPAR activity and methods of preparation |
| JPWO2005054213A1 (ja) * | 2003-12-02 | 2007-12-06 | 塩野義製薬株式会社 | ペルオキシソーム増殖活性化受容体アゴニスト活性を有するイソキサゾール誘導体 |
| JP2007538102A (ja) * | 2004-05-20 | 2007-12-27 | バイエル・フアーマシユーチカルズ・コーポレーシヨン | 糖尿病の処置に有用な５−アニリノ−４−ヘテロアリールピラゾール誘導体 |
| JP2008500358A (ja) * | 2004-05-25 | 2008-01-10 | メタボレックス インコーポレーティッド | Ｐｐａｒのモジュレーターとしての、二環式の置換されたトリアゾール、およびこれらの調製方法 |
| EP1887000A4 (en) * | 2005-05-27 | 2011-09-07 | Shionogi & Co | ARYLACETATE DERIVATIVES WITH ISOXAZO EASY |
-
2006
- 2006-07-04 CN CNA2006800311061A patent/CN101248065A/zh active Pending
- 2006-07-04 EP EP06780910A patent/EP1916247A4/en not_active Withdrawn
- 2006-07-04 AU AU2006266711A patent/AU2006266711A1/en not_active Abandoned
- 2006-07-04 BR BRPI0612396A patent/BRPI0612396A2/pt not_active IP Right Cessation
- 2006-07-04 CA CA002614315A patent/CA2614315A1/en not_active Abandoned
- 2006-07-04 RU RU2008104422/04A patent/RU2008104422A/ru not_active Application Discontinuation
- 2006-07-04 ZA ZA200800892A patent/ZA200800892B/xx unknown
- 2006-07-04 KR KR1020087002931A patent/KR20080032155A/ko not_active Application Discontinuation
- 2006-07-04 US US11/988,354 patent/US20100029949A1/en not_active Abandoned
- 2006-07-04 JP JP2007523451A patent/JPWO2007004733A1/ja not_active Ceased
- 2006-07-04 WO PCT/JP2006/313636 patent/WO2007004733A1/ja active Application Filing
-
2008
- 2008-01-06 IL IL188616A patent/IL188616A0/en unknown
- 2008-02-04 NO NO20080628A patent/NO20080628L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2614315A1 (en) | 2007-01-11 |
| EP1916247A1 (en) | 2008-04-30 |
| AU2006266711A1 (en) | 2007-01-11 |
| ZA200800892B (en) | 2009-04-29 |
| EP1916247A4 (en) | 2009-07-15 |
| CN101248065A (zh) | 2008-08-20 |
| US20100029949A1 (en) | 2010-02-04 |
| NO20080628L (no) | 2008-03-31 |
| JPWO2007004733A1 (ja) | 2009-01-29 |
| IL188616A0 (en) | 2008-04-13 |
| KR20080032155A (ko) | 2008-04-14 |
| WO2007004733A1 (ja) | 2007-01-11 |
| RU2008104422A (ru) | 2009-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTC2343304I2 (lt) | Biocidiniai boronoftalido junginiai | |
| BRPI0716171A2 (pt) | composto, composiÇço farmacÊutica e uso de um composto. | |
| BRPI0717757A2 (pt) | Derivado de haloalquilsulfoanilida ou um sal do mesmo, herbicida, e, método para usar um herbicida | |
| BRPI0609802A2 (pt) | composto, composição farmacêutica e uso de um composto | |
| BRPI0812877A2 (pt) | " compostos de piperazina, uso de um composto de piperazina, composição, e, método para combater vegetação indesejada ". | |
| BRPI0815709A2 (pt) | composro, composição farmacêutica, e, uso de um composto. | |
| BRPI0618904A2 (pt) | composto, composição farmacêutica, e, uso do composto | |
| BRPI0614205A2 (pt) | composto, composição farmacêutica, e, uso de composto | |
| BRPI0614159A2 (pt) | implemento para cuidado oral | |
| BRPI0614162A2 (pt) | dermocosmético, e, uso de um composto | |
| BRPI0813863A2 (pt) | Derivado de oxopirazina ou um sal agroquimicamente aceitável do mesmo, composto, herbicida, e, método para usar um herbicida | |
| BRPI0614730A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| ATE518848T1 (de) | 3, 6-dihydro-2-oxo-6h-(1,3,4)thiadiazinderivate | |
| BRPI0612396A2 (pt) | composto ou um sal do mesmo, e, ativador para receptor ativado por proliferador de peroxissoma delta | |
| DE602006000612D1 (de) | Beidseitig tragbare Orthese | |
| BRPI0609178A2 (pt) | composto ou um sal do mesmo, e, ativador para o receptor ativado do proliferador de peroxissoma delta | |
| BRPI0614413A2 (pt) | composto, e, composição farmacêutica | |
| FI20060450L (fi) | Järjestelmä toimisylinterin asemoimiseksi, järjestelmän käyttö ja työkone | |
| BRPI0610177A2 (pt) | composto ou um sal do mesmo, e, ativador para receptor ativado por proliferador de peroxissomo | |
| BRPI0614412A2 (pt) | composto, e, composição farmacêutica | |
| DE502006000922D1 (de) | Richtung | |
| BRPI0612270A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0816800A2 (pt) | Composto, composição farmacêutica, e, uso de um composto. | |
| ES1057901Y (es) | Dispositivo de articulacion para brazos de toldos o similares. | |
| ITAN20060013U1 (it) | Dispositivo di arresto per ante, porte, imposte o simili |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06G | Technical and formal requirements: other requirements [chapter 6.7 patent gazette] |
Free format text: SOLICITA-SE A REGULARIZACAO DA PROCURACAO, UMA VEZ QUE BASEADO NO ARTIGO 216 PAR 1O DA LPI, O DOCUMENTO DE PROCURACAO DEVE SER APRESENTADO NO ORIGINAL, TRASLADO OU FOTOCOPIA AUTENTICADA. |
|
| B11Z | Dismissal: petition dismissal - article 216, par 2 of industrial property law |
Free format text: REFERENTE A PETICAO NO 20080002158/RJ DE 04/01/2008. |
|
| B11M | Decision cancelled [chapter 11.13 patent gazette] |
Free format text: O DESPACHO 11.6.1 ESTA SENDO ANULADO TENDO POR BASE A DETERMINACAO DO DIRETOR DE PATENTES, A QUAL E CALCADA NO PARECER NO 0003-2014 AGU/PGF/PFE/INPI/COOPHI-LBC-1.0. |
|
| B06H | Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette] |
Free format text: O DESPACHO 6.7 ESTA SENDO ANULADO TENDO POR BASE A DETERMINACAO DO DIRETOR DE PATENTES, A QUAL E CALCADA NO PARECER NO 0003-2014 AGU/PGF/PFE/INPI/COOPHI-LBC-1.0. |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |